Briviact Shortage Update: What Patients Need to Know in 2026

The Latest on Briviact Availability in 2026

If you've been having trouble filling your Briviact (brivaracetam) prescription, you're probably wondering: is there an actual shortage? The answer is nuanced — and important to understand so you can take the right steps.

Let's break down exactly what's happening with Briviact availability in 2026, why you might be struggling to find it, and what you can do about it.

Is Briviact Still in Shortage?

As of March 2026, Briviact is not listed in an official FDA drug shortage. The FDA maintains a public database of medications experiencing supply disruptions, and brivaracetam does not appear on it.

However, that doesn't mean it's easy to find. There's a difference between a formal drug shortage (where manufacturing or supply chain issues limit nationwide availability) and a findability problem (where the medication exists but isn't widely stocked at retail pharmacies). Briviact falls firmly in the second category.

We rate Briviact's findability at 55 out of 100 — meaning patients face moderate difficulty locating it at their usual pharmacy. It's not impossible to find, but you may need to look beyond your regular chain pharmacy.

Why Is Briviact Hard to Find?

Several factors make Briviact harder to locate than common medications:

Limited Retail Pharmacy Stocking

Briviact is a specialty anti-epileptic prescribed primarily by neurologists. Chain pharmacies like CVS, Walgreens, and Rite Aid stock medications based on demand volume. If a location only fills a few Briviact prescriptions per month — or none — it won't keep the medication on hand.

No Widely Available Generic Tablet

While Lupin received FDA approval for a generic brivaracetam oral solution in February 2026, generic tablets have not yet launched broadly in the U.S. This means most patients are still filling brand-name Briviact, which has a higher cost and lower distribution footprint.

Schedule V Controlled Substance

Briviact is classified as a DEA Schedule V controlled substance. While this is the lowest level of controlled scheduling, it still adds ordering, storage, and reporting requirements that some pharmacies prefer to avoid for low-volume medications.

Specialty Distribution Channels

UCB distributes Briviact through specific wholesaler networks. Not every retail pharmacy has equal access to every wholesaler's catalog, which can create local availability gaps even when the national supply is adequate.

What Does Briviact Cost in 2026?

Cost is often intertwined with availability — and for Briviact, it's significant:

• Brand-name Briviact tablets: Approximately $1,500 to $2,000 per month (60 tablets of 100 mg) at retail cash price
• With UCB Savings Card: Eligible commercially insured patients may pay as low as $10 per prescription
• Generic brivaracetam oral solution (Lupin): Pricing still emerging, but expected to be lower than brand
• Anticipated generic tablet pricing: $200 to $600 per month when widely available

If cost is a barrier, we have a detailed guide on how to save money on Briviact that covers savings cards, patient assistance programs, and discount strategies.

New Options and Developments

Generic Brivaracetam Oral Solution

The biggest development in 2026 is Lupin's FDA approval of generic brivaracetam oral solution (10 mg/mL) in February 2026. While this isn't a tablet formulation (which is what most patients take), it represents the beginning of generic competition for brivaracetam. More generic approvals — including tablets — are expected to follow.

Specialty Pharmacy Networks

More specialty pharmacy networks are recognizing the demand for epilepsy medications and expanding their formularies. If your insurance plan has a specialty pharmacy option, it's worth checking whether they carry Briviact.

How to Find Briviact in Stock

Here are practical steps you can take today:

1. Use Medfinder to search for pharmacies near you that have Briviact available. This is the fastest way to check multiple pharmacies at once.
2. Call independent pharmacies. They have more flexibility in ordering and are often willing to special-order Briviact within 1-3 business days.
3. Contact your neurologist's office. They often know which local pharmacies reliably stock Briviact and may be able to call ahead for you.
4. Check specialty and mail-order pharmacies. These typically have larger inventories of specialty medications and can ship to your home.
5. Start refills early. Don't wait until your last dose — begin the refill process at least 7-10 days before you run out.

For more detailed strategies, see our complete guide on how to find Briviact in stock near you.

What If You Can't Find Briviact at All?

If you've exhausted your options and genuinely cannot find Briviact, talk to your neurologist about alternatives. Medications like Levetiracetam (Keppra), Lacosamide (Vimpat), and Perampanel (Fycompa) are potential substitutes — though each has different benefits and trade-offs.

Never stop taking Briviact abruptly. Sudden discontinuation of anti-seizure medications can trigger withdrawal seizures, including potentially dangerous seizure clusters or status epilepticus. If you're running low, treat it as urgent and contact your neurologist right away.

Final Thoughts

Briviact is not in a formal shortage in 2026, but real-world availability remains challenging for many patients. The specialty nature of the medication, lack of generic tablets, controlled substance requirements, and limited retail stocking all contribute to the problem.

The situation is slowly improving — generic brivaracetam is beginning to enter the market, and awareness of the availability issue is growing among pharmacies and healthcare providers. In the meantime, tools like Medfinder, independent pharmacies, and proactive refill planning are your best strategies for staying supplied.